LUNG FUNG GROUP

In the deep end of the Hong Kong stock market, there are a bunch of inconspicuous names, $LUNG FUNG GROUP(02290.HK), $SMART FISH(00139.HK), $BUTONG GROUP(06090.HK), $EKH(02523.HK). These small-cap stocks usually don't make much of a splash. $TRAVELSKY TECH(00696.HK) makes a living from ticket distribution, with low attention and thin liquidity🫥

$LUNG FUNG GROUP(02290.HK)、$FENBI(02469.HK) One is a Hong Kong small-cap stock, the other is online education, neither really aligns with mainstream themes, and liquidity is average. I'll just put them on the watchlist as filler material for now and keep an eye out for any unusual movements. 🙃

$LUNG FUNG GROUP(02290.HK) hides in the corner of Hong Kong stocks doing small consumer business, $MOST KWAI CHUNG(01716.HK) relies on local Hong Kong satire content for a living, and $Velo3D(VELO.US) does metal 3D printing in the US stock market. These three obscure names usually have little presence and are only remembered when mentioned, realizing they're still around👀

$LUNG FUNG GROUP(02290.HK) After the earnings report, it rose from over $2 to $3.6. I bought it at $6 in the grey market, and now there's hardly any liquidity, so I took a loss of 2500 and left. The IPO subscription on Longbridge in June didn't feel as lively as when there were more people before.

$LUNG FUNG GROUP(02290.HK) got in at a grey market price of 6 yuan, it plummeted to 2 yuan, now it's at 3.6 yuan, should I sell or hold?

$LUNG FUNG GROUP(02290.HK) surged over 14%. The trigger point was the just-announced annual profit increase of +57% year-on-year, coupled with the end of the post-IPO price stabilization period where underwriters no longer support the price. After this suppression was removed, the price made a one-time upward adjustment.$BUSYMING(01768.HK) rose nearly 10% here. The logic is its inclusion in the Stock Connect (for Hong Kong) and Macquarie raising its profit forecast and target price—both events serve to attract incremental capital and institutional attention.

Both are secondary new consumer stocks, relying on solid performance and capital market events, not sentiment-driven pumps. This kind of driver is more solid than pure thematic plays, but secondary new stocks have high volatility, so position sizing must be controlled when chasing.

$LUNG FUNG GROUP(02290.HK)You've broken my fiery heartᗜⰙᗜ(•̩̩̩̩＿•̩̩̩̩)

$LUNG FUNG GROUP(02290.HK) rose slightly, $EASTROC(09980.HK) fell slightly, and $CTIHK(06055.HK) fell slightly. These three food and beverage stocks showed some divergence on the Hong Kong market today—$LUNG FUNG GROUP(02290.HK) is a small-cap food stock in Hong Kong, moving with sentiment; $EASTROC(09980.HK) saw the end of pre-season warm-up before the Q2 sales peak, with a PE of 40x already reflecting expectations for new flavors, making its valuation not cheap; $CTIHK(06055.HK) is a steady state of high dividend yield + overseas business.

$GIANT BIOGENE(02367.HK) rose five points, which is quite eye-catching; the medical aesthetics sector has its own momentum. $LUNG FUNG GROUP(02290.HK) and $PepsiCo(PEP.US) both edged up slightly, with consumer staples holding steady. $LI NING(02331.HK) dipped slightly 😏

The consumer sector has been uneven lately. Sectors with stories like medical aesthetics and resilient consumer staples are turning green, while discretionary consumption like sportswear remains relatively weak. Their underlying demand logic is different.

$PepsiCo(PEP.US) and $Draftkings(DKNG.US) barely moved, $ANTA SPORTS(02020.HK) dipped slightly, $CTG DUTY-FREE(01880.HK) fell four percentage points, $Sadot(SDOT.US) dropped five to six percentage points, and $LUNG FUNG GROUP(02290.HK) plunged nine percentage points—the consumer sector as a whole is weak, with internal stratification. Overseas essential consumption remained stable, while Hong Kong-listed discretionary consumption and duty-free stocks were dragged down by domestic demand expectations, with small-cap consumer stocks falling even deeper. As risk appetite returns, money is actually flowing out of these defensive and weak-recovery consumer plays. The consumer sector is being neglected in the short term.

$LUNG FUNG GROUP(02290.HK) is really a company that's going under, falling every day, already halved.

$Rubico(RUBI.US) plummeted -24% in a single day, which is particularly glaring. $CPS Tech(CPSH.US) and $LUNG FUNG GROUP(02290.HK) also fell by eight or nine percentage points. The three completely unrelated sectors of oil shipping, chemical materials, and consumer goods all collapsed today. The simultaneous sharp decline of unrelated small-cap stocks—did each step on its own landmine, or is it due to poor small-cap liquidity being pushed down by the same wave of capital withdrawal? It seems more like the latter. Looking at each individually, no common negative catalyst is apparent. High-volatility small caps are often indiscriminately sold off on days when risk appetite contracts. $Rubico(RUBI.US) fell so hard. Should we rush to buy the dip or hide first? Personally, I don't dare to catch the falling knife. 🙈

Subscribing at 4000 times oversubscription doesn't necessarily make money, but subscribing at less than 100 times oversubscription is definitely a loss. The 6000-times-oversubscribed Uisee Technology and the 4000-times-oversubscribed Longfeng Group were my biggest pitfalls in a year of subscribing.

$CCSC Tech(CCTG.US) down 50% in a single day, $Youlife(YOUL.US) down 48%, $Core AI(CHAI.US) also dropped over 20%, and $LUNG FUNG GROUP(02290.HK) followed with a 7% drop — the small-cap meme stocks that were surging in rotation recently have collectively receded 😵

There's no logic when they go up, and no logic is needed when they go down. With such small float, the big money itself becomes the market. Not holding these stocks in my account makes me happier than seeing any positive news 🙏

$LIULIUMEI(06658.HK) next Longfeng Group and Tong Shifu

$LUNG FUNG GROUP(02290.HK) is really something; it doesn't rise if you don't sell, but as soon as you sell, it goes up.

Worth watching!!